Advertisement

Resistance of Herpes Viruses to Nucleoside Analogues — Mechanisms and Clinical Importance

  • C. Crumpacker
Part of the Developments in Medical Virology book series (DIMV, volume 3)

Abstract

The study of resistance to antiviral drugs provides an important method to determine mechanisms of drug action. A mutation in the gene for a viral enzyme which enables a virus to replicate in the presence of the active form of a drug provides evidence that the mechanism of action involves the viral gene product. In the study of DNA replication, Kornberg observed that mutants possessing temperature sensitive and drug resistant mutations were the most important classes of mutants for defining precise mechanisms of DNA replication (1). A key feature in showing that the current class of antiviral drugs are specific for herpes viruses has been related to the fact that they readily select for resistance in herpes viruses and the resistance markers can be mapped to viral specific functions. Another important reason to study resistance of herpes viruses to antiviral drugs is that resistance can occur in the course of clinical treatment of herpes virus infections and development of resistance may account for failure of antiviral therapy. Resistant mutants of herpes viruses may also possess altered pathogenetic properties and produce unusual disease manifestations. In this review, the mechanisms of resistance to various nucleoside analogues will be outlined, and the cases where clinical resistance has been observed will be summarized.

Keywords

Thymidine Kinase Nucleoside Analogue Antiviral Drug Herpes Virus Genital Herpes 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kornberg, A. In: DNA Replication. Chapter 13. Freeman, New York, 1980.Google Scholar
  2. 2.
    Elion, G.B., Furman, P.A., Fyfe, J.A., de Miranda, P., Beauchamp, L. and Schaeffer, E.J. Proc. Natl. Acad. Sci. USA 74: 5716–5720, 1977.PubMedCrossRefGoogle Scholar
  3. 3.
    Miller, W.H. and Miller, R.L. J. Biol. Chem. 255: 7204–7207, 1980.PubMedGoogle Scholar
  4. 4.
    Terse, D., Cheng, Y.-C, Furman, P.A., St. Clair, K.R. and Elion, G.B. J. Biol. Chem. 256: 11447–11451, 1981.Google Scholar
  5. 5.
    Furman, P.A., St. Clair, M.H., Fyfe, J.A., Rideout, J.L., Keller, P.M. and Elion, G.L. J. Virol. 32: 72–77, 1979.PubMedGoogle Scholar
  6. 6.
    Furman, P.A., St. Clair, M.H. and Spector, T. J. Biol. Chem. 259: 9575–9579, 1984.PubMedGoogle Scholar
  7. 7.
    Knopf, K.W., Kaufman, E.R. and Crumpacker, C. J. Virol. 39: 746–757, 1981.PubMedGoogle Scholar
  8. 8.
    Field, A.K., Davies, M.E., DeWitt, C., Perry, H.C., Liou, R., Germershausen, J., Karkas, J.D., Ashton, W.T., Johnston, D.B.R. and Tolman, R.L. Proc. Natl. Acad. Sci. USA 80: 4139–4143, 1983.PubMedCrossRefGoogle Scholar
  9. 9.
    Cheng, Y.-C, Grill, S.P., Dutschman, G.E., Nakayama, K. and Bastow, K.F. J. Biol. Chem. 258: 12460–12464, 1983.PubMedGoogle Scholar
  10. 10.
    Mar, E.-C, Chiou, J.-F., Cheng, Y.-C. and Huang, E.-S. J. Virol. 53: 776–780, 1985.PubMedGoogle Scholar
  11. 11.
    Tocci, M.J., Livelli, T.J., Perry, H.C., Crumpacker, C.S. and Field, A.K. Antimicrob. Agents Chemother. 25: 247–252, 1984.PubMedGoogle Scholar
  12. 12.
    Collaborative DHPG Treatment Study Group. New Engl. J. Med. 314: 801–806, 1986.CrossRefGoogle Scholar
  13. 13.
    Smee, D.F. Mol. Cell. Biochem. 69: 75–81, 1985.PubMedCrossRefGoogle Scholar
  14. 14.
    Biron, K.K., Fyfe, J.A., Stanat, S.C., Leslie, L.K., Sorrell, J.B., Lambe, C.U. and Coen, D.M. Proc. Natl. Acad. Sci. USA 83: 8769–8773, 1986.PubMedCrossRefGoogle Scholar
  15. 15.
    Oliver, S., Bubley, G. and Crumpacker, C. Virology 145: 84–93, 1985.PubMedCrossRefGoogle Scholar
  16. 16.
    De Clercq, E., Descamps, J., De Somer, P., Barr, P.J., Jones, A.S. and Walker, R.T. Proc. Natl. Acad. Sci. USA 76: 2947–2951, 1979.PubMedCrossRefGoogle Scholar
  17. 17.
    Crumpacker, C.S., Schnipper, L.E., Kowalsky, P.N. and Sherman, D.M. J. Infect. Dis. 146: 167–172, 1982.PubMedCrossRefGoogle Scholar
  18. 18.
    Balzarini, J., De Clercq, E., Verbruggen, A., Crumpacker, C., Ayusawa, D. and Seno, T. Anticancer Res. 6: 1077–1084, 1986.PubMedGoogle Scholar
  19. 19.
    Pelling, J.C., Drach, J.C. and Shipman, C. Jr. Virolcgy 109: 323–335, 1981.CrossRefGoogle Scholar
  20. 20.
    Derse, D. and Cheng, Y.-C. J. Biol. Chem. 256: 8525–8530, 1981.PubMedGoogle Scholar
  21. 21.
    Schnipper, L.E. and Crumpacker, C.S. Proc. Natl. Acad. Sci. USA 77: 2270–2273, 1980.PubMedCrossRefGoogle Scholar
  22. 22.
    Darby, G., Field, H.J. and Salisbury, S.A. Nature 289: 81–83, 1981.PubMedCrossRefGoogle Scholar
  23. 23.
    Larder, B.A., Derse, D., Cheng, Y.-C. and Darby, G. J. Biol. Chem. 258: 2027–2033, 1983.PubMedGoogle Scholar
  24. 24.
    Larder, B.A., Cheng, Y.-C. and Darby, G. J. Gen. Virol. 64: 523–532, 1983.PubMedCrossRefGoogle Scholar
  25. 25.
    Shigeta, S., Yokota, T., Iwabuchi, T., Baba, M., Konno, K., Ogata, M. and De Clercq, E. J. Infect. Dis. 147: 576–584, 1983.PubMedCrossRefGoogle Scholar
  26. 26.
    Coen, D.M. and Schaffer, P.A. Proc. Natl. Acad. Sci. USA 77: 2265–2269, 1980.PubMedCrossRefGoogle Scholar
  27. 27.
    Coen, D.M., Furman, P.A., Gelep, P.T. and Schaffer, P.A. J. Virol. 41: 909–918, 1982.PubMedGoogle Scholar
  28. 28.
    Parris, D.S. and Harrington, J.E. Antimicrob. Agents Chemother. 22: 71–77, 1982.PubMedGoogle Scholar
  29. 29.
    Chartrand, P., Stow, N.D., Timbury, M.C. and Wilkie, N.M. J. Virol. 31: 265–276, 1979.PubMedGoogle Scholar
  30. 30.
    Crumpacker, C.S., Chartrand, P., Subak-Sharpe, J.K. and Wilkie, N.M. Virology 205: 171–184, 1980.CrossRefGoogle Scholar
  31. 31.
    Gibbs, J.S., Chiou, H.C., Hall, J.D., Mount, D.W., Retondo, M.J., Weiler, S.K. and Coen, D.M. Proc. Natl. Acad. Sci. USA 82: 7969–7973, 1985.PubMedCrossRefGoogle Scholar
  32. 32.
    Crumpacker, CS., Kowalsky, P.N., Oliver, S.A., Schnipper, L.E. and Field, A.K. Proc. Natl. Acad. Sci. USA 81: 1556–1560, 1984.PubMedCrossRefGoogle Scholar
  33. 33.
    Frank, K.B., Chiou, J.-F. and Cheng, Y.-C. J. Biol. Chem. 259: 1566–1569, 1984.PubMedGoogle Scholar
  34. 34.
    Furman, P.A., Coen, D.M., St. Clair, M.H. and Schaffer, P.A. J. Virol. 40: 936–941, 1981.PubMedGoogle Scholar
  35. 35.
    Quinn, J.P. and McGeoch, D.J. Nucleic Acids Res. 13: 8143–8163, 1985.PubMedCrossRefGoogle Scholar
  36. 36.
    Knopf, C.W. Nucleic Acids Res. 14: 8225–8226, 1986.PubMedCrossRefGoogle Scholar
  37. 37.
    Holland, L.E., Sandri-Goldin, R.M., Goldin, A.L., Glorioso, J.C. and Le-vine, M. J. Virol. 49: 947–959, 1984.PubMedGoogle Scholar
  38. 38.
    Chartrand, P., Crumpacker, C.S., Schaffer, P.A. and Wilkie, N.M. Virology 103: 311–326, 1980.PubMedCrossRefGoogle Scholar
  39. 39.
    Coen, D.M., Aschman, D.P., Gelep, P.T., Retondo, M.J., Weller, S.K. and Schaffer, P.A. J. Virol. 49: 236–247, 1984.PubMedGoogle Scholar
  40. 40.
    Kouzarides, T., Bankier, A.T., Satchwell, S.C., Weston, K., Tomlinson, P. and Barrell, B.G. J. Virol. 61: 125–133, 1987.PubMedGoogle Scholar
  41. 41.
    Reinhold, R. et al. J. Virol. 61, in press, 1987.Google Scholar
  42. 42.
    Larder, B.A., Kemp, S.D. and Darby, G. EMBO J. 6: 169–175, 1987.PubMedGoogle Scholar
  43. 43.
    Crumpacker, CS., Schnipper, L.E., Marlowe, S.I., Kowalsky, P.N., Hershey, B.J. and Levin, M.J. New Engl. J. Med. 306: 343–346, 1982.PubMedCrossRefGoogle Scholar
  44. 44.
    Sibrack, D., Gutman, L.T., Wilfert, CM., McLaren, C, St. Clair, M.H., Keller, P.M. and Barry, D.W. J. Infect. Dis. 146: 673–682, 1982.PubMedCrossRefGoogle Scholar
  45. 45.
    Burns, W.H., Sarai, R., Santcs, G.W., Laskin, O.L, Lietman, P.S., McLaren, C and Barry, D.W. Lancet i: 421–423, 1982.CrossRefGoogle Scholar
  46. 46.
    Wade, J.C., Newton, B., McLaren, C., Flournoy, N., Keeney, R.E. and Meyers, J.D. Ann. Intern. Med. 96: 265–269, 1982.PubMedGoogle Scholar
  47. 47.
    Chatis, P., Germershausen, J., Field, A.K. and Crumpacker, C.S. Abstract of the 11th International Herpes Workshop, 1985.Google Scholar
  48. 48.
    Schinazi, R.F., del Bene, V., Scctt, R.T. and Dudley-Thorpe, J.-B. J. Antimicrob. Agents Chemother. 18 (Suppl. B): 127–134, 1986.Google Scholar
  49. 49.
    Svennerholm, E., Vahlne, A., Löwhagen, G.B., Widell, A. and Lycke, E. Scand. J. Infect. Dis., Suppl. 47: 149–154, 1985.Google Scholar
  50. 50.
    Field, H.J. and Wildy, P. J. Hygiene 81: 267–277, 1978.CrossRefGoogle Scholar
  51. 51.
    Tenser, R.B. and Dunstan, M.E. Virology 99: 417–422, 1979.PubMedCrossRefGoogle Scholar
  52. 52.
    Tenser, R.B., Miller, R.L. and Rapp, F. Science 205: 915–917, 1979.PubMedCrossRefGoogle Scholar
  53. 53.
    Straus, S.E., Takiff, H.E., Seidlin, M., Bachrach, S., Lininger, L., Di-Giovanna, J.J., Western, K.A., Smith, H.A., Nusinoff Lehrman, S., Creagh-Kirk, T. and Alling, D.W. New Engl. J. Med. 310: 1545–1550, 1984.PubMedCrossRefGoogle Scholar
  54. 54.
    Field, H.J. and Coen, D.M. J. Virol. 60: 286–289, 1986.PubMedGoogle Scholar
  55. 55.
    ïolman, R.L., Field, A.K., Karkas, J.D., Wagner, A.F., Germershausen, J., Crumpacker, C. and Scolnick, E.M. Biochem. Biophys. Res. Commun. 128: 1329–1335, 1985.CrossRefGoogle Scholar
  56. 56.
    De Clercq, E., Holy, A., Rosenberg, I., Sakuma, T., Balzarini, J. and Maucgal, P.C. Nature 323: 464–467, 1986.PubMedCrossRefGoogle Scholar
  57. 57.
    Marlowe, S.I., Kowalsky, P.A., Douglas, J., Corey, C. and Crumpacker, C.S. Abstract of the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1984.Google Scholar
  58. 58.
    Nusinoff Lehrman, S., Douglas, J.M., Corey, L. and Barry, D.W. Ann. Intern. Med. 104: 786–790, 1986.Google Scholar
  59. 59.
    Field, H., McMillan, A. and Darby, G. J. Infect. Dis. 143: 281–285, 1981.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing 1988

Authors and Affiliations

  • C. Crumpacker
    • 1
  1. 1.Harvard Medical SchoolBeth Israel HospitalBostonUSA

Personalised recommendations